| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
Other Original Articles |
Departments of Medicine, Human Genetics, and Physiology, McGill University and Calcium Research Laboratory, Royal Victoria Hospital (L.D.-L., B.Y., L.C., G.N.H.), Montréal, Quebéc, Canada H3A 1A1; Department of Medicine, University of Calgary (D.A.H.), Alberta, Canada T2N 4N1; Department of Medicine, Harvard Medical School and Endocrine Unit, Massachusetts General Hospital (M.B.), Boston, Massachusetts 02114; Departments of Pediatrics and Medicine, Dalhousie University (S.R.S.), Halifax, Nova Scotia, Canada B3J 3G9; Endocrine-Hypertension Division and Membrane Biology Program, Brigham and Womens Hospital, and Harvard Medical School (M.B., E.M.B.), Boston, Massachusetts 02114; and Departments of Laboratory Medicine and Pathobiology, Medicine, and Genetics, University of Toronto and The Banting Institute (D.E.C.C.), Toronto, Ontario, Canada M5G 1L5
Address all correspondence and requests for reprints to: Geoffrey N. Hendy, Ph.D., Calcium Research Laboratory, Room H4.67, Royal Victoria Hospital, 687 Pine Avenue West, Montreal, Quebéc, Canada H3A 1A1. E-mail: . gnhendy{at}med.mcgill.ca
Abstract
Familial hypocalciuric hypercalcemia (FHH), neonatal severe hyperparathyroidism (NSHPT), and autosomal dominant hypocalcemia (ADH), in which calcium homeostasis is disordered, are associated with mutations in the calcium-sensing receptor (CASR). Six unrelated kindreds with FHH and/or NSHPT and two unrelated kindreds with ADH were studied. Direct sequence analysis of the exons of the CASR gene identified heterozygous mutations in six of the kindreds with FHH and in one of those with ADH. We performed functional analyses on the novel missense and insertion/frameshift mutants by transiently transfecting wild-type and mutant CASRs tagged with a c-Myc epitope in human embryonic kidney (HEK293) cells. All mutant receptors were expressed at a similar level to that of the wild type; however, whereas mutants R220W and A835T (the ADH mutant) were fully glycosylated and were visualized on the cell surface, glycosylation of mutants G549R and C850^851 ins/fs was impaired, resulting in reduced cell surface staining. In fura-2-loaded HEK293 cells expressing the wild-type or mutant receptors, the inactivating R220W mutant produced a significant shift to the right relative to the wild-type CASR in the cytosolic calcium response to increasing extracellular calcium concentrations and the G549R and C850^851 ins/fs mutants were without detectable activity. The activating A835T mutation resulted in a shift to the left in the cytosolic calcium response to extracellular calcium concentrations relative to the wild type. Our studies have identified novel CASR mutations that alter the function of the CASR in several different ways.
This article has been cited by other articles:
![]() |
M. Mannstadt, G. Bertrand, M. Muresan, G. Weryha, B. Leheup, S. R. Pulusani, B. Grandchamp, H. Juppner, and C. Silve Dominant-Negative GCMB Mutations Cause an Autosomal Dominant Form of Hypoparathyroidism J. Clin. Endocrinol. Metab., September 1, 2008; 93(9): 3568 - 3576. [Abstract] [Full Text] [PDF] |
||||
![]() |
L. Canaff, X. Zhou, and G. N. Hendy The Proinflammatory Cytokine, Interleukin-6, Up-regulates Calcium-sensing Receptor Gene Transcription via Stat1/3 and Sp1/3 J. Biol. Chem., May 16, 2008; 283(20): 13586 - 13600. [Abstract] [Full Text] [PDF] |
||||
![]() |
L. Fox, J. Sadowsky, K. P. Pringle, A. Kidd, J. Murdoch, D. E.C. Cole, and E. Wiltshire Neonatal Hyperparathyroidism and Pamidronate Therapy in an Extremely Premature Infant Pediatrics, November 1, 2007; 120(5): e1350 - e1354. [Abstract] [Full Text] [PDF] |
||||
![]() |
P. M. Conn, A. Ulloa-Aguirre, J. Ito, and J. A. Janovick G Protein-Coupled Receptor Trafficking in Health and Disease: Lessons Learned to Prepare for Therapeutic Mutant Rescue in Vivo Pharmacol. Rev., September 1, 2007; 59(3): 225 - 250. [Abstract] [Full Text] [PDF] |
||||
![]() |
T. Drueke, D. Martin, and M. Rodriguez Can calcimimetics inhibit parathyroid hyperplasia? Evidence from preclinical studies Nephrol. Dial. Transplant., July 1, 2007; 22(7): 1828 - 1839. [Full Text] [PDF] |
||||
![]() |
K. Zajickova, J. Vrbikova, L. Canaff, P. D. Pawelek, D. Goltzman, and G. N. Hendy Identification and Functional Characterization of a Novel Mutation in the Calcium-Sensing Receptor Gene in Familial Hypocalciuric Hypercalcemia: Modulation of Clinical Severity by Vitamin D Status J. Clin. Endocrinol. Metab., July 1, 2007; 92(7): 2616 - 2623. [Abstract] [Full Text] [PDF] |
||||
![]() |
S. Pidasheva, M. Grant, L. Canaff, O. Ercan, U. Kumar, and G. N. Hendy Calcium-sensing receptor dimerizes in the endoplasmic reticulum: biochemical and biophysical characterization of CASR mutants retained intracellularly Hum. Mol. Genet., July 15, 2006; 15(14): 2200 - 2209. [Abstract] [Full Text] [PDF] |
||||
![]() |
S. D. Mittelman, G. N. Hendy, R. A. Fefferman, L. Canaff, I. Mosesova, D. E. C. Cole, L. Burkett, and M. E. Geffner A Hypocalcemic Child with a Novel Activating Mutation of the Calcium-Sensing Receptor Gene: Successful Treatment with Recombinant Human Parathyroid Hormone J. Clin. Endocrinol. Metab., July 1, 2006; 91(7): 2474 - 2479. [Abstract] [Full Text] [PDF] |
||||
![]() |
S. Pidasheva, L. Canaff, W. F. Simonds, S. J. Marx, and G. N. Hendy Impaired cotranslational processing of the calcium-sensing receptor due to signal peptide missense mutations in familial hypocalciuric hypercalcemia Hum. Mol. Genet., June 15, 2005; 14(12): 1679 - 1690. [Abstract] [Full Text] [PDF] |
||||
![]() |
J. Hu, S. J. McLarnon, S. Mora, J. Jiang, C. Thomas, K. A. Jacobson, and A. M. Spiegel A Region in the Seven-transmembrane Domain of the Human Ca2+ Receptor Critical for Response to Ca2+ J. Biol. Chem., February 11, 2005; 280(6): 5113 - 5120. [Abstract] [Full Text] [PDF] |
||||
![]() |
A. Wystrychowski, S. Pidasheva, L. Canaff, J. Chudek, F. Kokot, A. Wiecek, and G. N. Hendy Functional Characterization of Calcium-Sensing Receptor Codon 227 Mutations Presenting as Either Familial (Benign) Hypocalciuric Hypercalcemia or Neonatal Hyperparathyroidism J. Clin. Endocrinol. Metab., February 1, 2005; 90(2): 864 - 870. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. Rodriguez, E. Nemeth, and D. Martin The calcium-sensing receptor: a key factor in the pathogenesis of secondary hyperparathyroidism Am J Physiol Renal Physiol, February 1, 2005; 288(2): F253 - F264. [Abstract] [Full Text] [PDF] |
||||
![]() |
K. Miyashiro, I. Kunii, T. D. Manna, H. C. de Menezes Filho, D. Damiani, N. Setian, and O. M. Hauache Severe Hypercalcemia in a 9-Year-Old Brazilian Girl Due to a Novel Inactivating Mutation of the Calcium-Sensing Receptor J. Clin. Endocrinol. Metab., December 1, 2004; 89(12): 5936 - 5941. [Abstract] [Full Text] [PDF] |
||||
![]() |
K. Ray, S. P. Ghosh, and J. K. Northup The Role of Cysteines and Charged Amino Acids in Extracellular Loops of the Human Ca2+ Receptor in Cell Surface Expression and Receptor Activation Processes Endocrinology, August 1, 2004; 145(8): 3892 - 3903. [Abstract] [Full Text] [PDF] |
||||
![]() |
G. N. Hendy, C. Minutti, L. Canaff, S. Pidasheva, B. Yang, Z. Nouhi, D. Zimmerman, C. Wei, and D. E. C. Cole Recurrent Familial Hypocalcemia Due to Germline Mosaicism for an Activating Mutation of the Calcium-Sensing Receptor Gene J. Clin. Endocrinol. Metab., August 1, 2003; 88(8): 3674 - 3681. [Abstract] [Full Text] [PDF] |
||||
![]() |
J. Hu, G. Reyes-Cruz, W. Chen, K. A. Jacobson, and A. M. Spiegel Identification of Acidic Residues in the Extracellular Loops of the Seven-transmembrane Domain of the Human Ca2+ Receptor Critical for Response to Ca2+ and a Positive Allosteric Modulator J. Biol. Chem., November 22, 2002; 277(48): 46622 - 46631. [Abstract] [Full Text] [PDF] |
||||
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
| Endocrinology | Endocrine Reviews | J. Clin. End. & Metab. |
| Molecular Endocrinology | Recent Prog. Horm. Res. | All Endocrine Journals |